ライフサイエンスコーパス: ACP

1 ACP and AAFP recommend that clinicians select the treatm

2 ACP incorporation into the novel orthodontic cement did

3 ACP is a stable and essential subunit of the eukaryotic

4 ACP mitogenome sequence analyses will facilitate ACP pop

5 ACP recommends against performing screening pelvic exami

6 ACP recommends portable sleep monitors in patients witho

7 ACP recommends that clinicians select between either cog

8 ACP was defined as the ability to enable individuals to

9 ACP-501 has an acceptable safety profile after a single

10 ACP-501 infusion rapidly decreased small- and intermedia

11 ACP-501 was well tolerated, and there were no serious ad

12 ACPs have a central role in transporting starting materi

13 Recommendation 1: ACP and AAFP recommend that clinicians initiate treatmen

14 RECOMMENDATION 1: ACP recommends management with increased fluid intake sp

15 RECOMMENDATION 1: ACP recommends that all adult patients receive cognitive

16 Recommendation 1: ACP recommends that clinicians choose corticosteroids, n

17 Recommendation 1: ACP recommends that clinicians offer pharmacologic treat

18 Recommendation 1: ACP recommends that clinicians prescribe metformin to pa

19 RECOMMENDATION 1: ACP recommends that clinicians should perform a risk ass

20 RECOMMENDATION 1: ACP recommends that clinicians use protein or amino acid

21 equences in cox1 and trnAsn regions with 100 ACPs, SNPs in nad1-nad4-nad5 locus through PCR with 252

22 atients (78%) had new injury versus 13 of 18 ACP patients (72%) (P=0.66).

23 Recommendation 2: ACP and AAFP recommend that clinicians consider initiati

24 RECOMMENDATION 2: ACP recommends bladder training in women with urgency UI

25 RECOMMENDATION 2: ACP recommends pharmacologic monotherapy with a thiazide

26 Recommendation 2: ACP recommends that clinicians consider adding either a

27 RECOMMENDATION 2: ACP recommends that clinicians should choose advanced st

28 Recommendation 2: ACP recommends that clinicians treat osteoporotic women

29 RECOMMENDATION 2: ACP recommends that clinicians use a shared decision-mak

30 RECOMMENDATION 2: ACP recommends that clinicians use hydrocolloid or foam

31 Recommendation 2: ACP recommends that clinicians use low-dose colchicine w

32 is guideline serves as an update to the 2012 ACP guideline on the same topic.

33 in nad1-nad4-nad5 locus through PCR with 252 ACP samples.

34 Recommendation 3: ACP and AAFP recommend that clinicians consider initiati

35 Recommendation 3: ACP recommends against initiating long-term urate-loweri

36 RECOMMENDATION 3: ACP recommends against using alternating-air mattresses

37 RECOMMENDATION 3: ACP recommends pelvic floor muscle training with bladder

38 Recommendation 3: ACP recommends that clinicians offer pharmacologic treat

39 RECOMMENDATION 3: ACP recommends that clinicians use electrical stimulatio

40 Recommendation 4: ACP recommends against bone density monitoring during th

41 RECOMMENDATION 4: ACP recommends against treatment with systemic pharmacol

42 Recommendation 4: ACP recommends that clinicians discuss benefits, harms,

43 Recommendation 5: ACP recommends against using menopausal estrogen therapy

44 RECOMMENDATION 5: ACP recommends pharmacologic treatment in women with urg

45 ective randomized observational study in 598 ACP patients who underwent CTA versus SPECT.

46 Recommendation 6: ACP recommends that clinicians should make the decision

47 RECOMMENDATION 6: ACP recommends weight loss and exercise for obese women

48 Acalabrutinib (ACP-196) is a highly selective, potent Bruton tyrosine k

49 Acalabrutinib (ACP-196) is a more selective, irreversible BTK inhibitor

50 in a manner that would exclude the acceptor ACP.

51 and could not be substituted by the acceptor ACP.

52 interactions between the type II fatty acid ACP from Escherichia coli, AcpP, and its corresponding e

53 hioesterase hydrolyzed the accumulating acyl-ACP in the DeltaplsX strain to liberate fatty acids that

54 The CT776 gene encodes an acyl-ACP synthetase (AasC) with a substrate preference for pa

55 g AasC, illustrating its function as an acyl-ACP synthetase in vivo.

56 enic pathways and rewiring acyl-CoA and acyl-ACP (acyl carrier protein) metabolism in Yarrowia lipoly

57 firmed the sensitivity of the bacterial acyl-ACP synthase to these drugs in infected human cells.

58 CT775 accepts both acyl-ACP and acyl-CoA as acyl donors and, 1- or 2-acyl isomer

59 in act1, which encodes the chloroplast acyl-ACP:glycerol-3-phosphate acyltransferase, and one in lpa

60 in lpat1, which encodes the chloroplast acyl-ACP:lysophosphatidic acid acyltransferase.

61 Specifically, acyl-CoA/acyl-ACP processing enzymes were targeted to the cytoplasm, p

62 lipid synthesis in bacteria, converting acyl-ACP to acyl-phosphate on the pathway to phosphatidic aci

63 selectively transfers fatty acids from acyl-ACP to the 1-position of 2-acyl-glycerophospholipids.

64 ntrast, TE2 prefers an engineered human acyl-ACP substrate and readily releases short chain fatty aci

65 thioesterase (TesS, SP1408) hydrolyzed acyl-ACP in vitro, and the DeltatesS DeltaplsX double knockou

66 the rapid accumulation of intracellular acyl-ACP and the abrupt cessation of fatty acid synthesis.

67 ssay of toxin activation and binding of acyl-ACP and protoxin peptide substrates by mutated ApxC vari

68 ganization, like the soluble plastidial acyl-ACP desaturases.

69 PlsX generates acyl-PO4 from the acyl-ACP end-products of fatty acid synthesis.

70 el in which LYR proteins associate with acyl-ACP as a mechanism for fatty acid biosynthesis to coordi

71 ntral infarctions occurred exclusively after ACP (0 vs. 6/18 [33%]; P=0.02).

72 tral infarctions occurring exclusively after ACP.

73 dence of perioperative cerebral injury after ACP compared with DHCA.

74 ulfide-containing alkenylidenecyclopropanes (ACPs) to afford five-membered carbo- and heterocyclic ri

75 trans-disubstituted alkylidenecyclopropanes (ACPs) with imidazolidin-2-ones and other nucleophiles.

76 a Chinese ACP cluster (CAC) and an American ACP cluster (AAC).

77 the solution exposure of the Ppant arm of an ACP from 6-deoxyerythronolide B synthase (DEBS).

78 otoelectron spectroscopy analysis of ABP and ACP confirmed that both samples contain high levels of o

79 hat there was no difference between DHCA and ACP in terms of new cerebral injury.

80 h and avert dire environmental outcomes, and ACP believes that physicians can play a role in achievin

81 ance energy transfer combined with SNAP- and ACP-tag labeling in COS7 cells to monitor dimerization o

82 medical professional organizations, such as ACP, also function intentionally as moral agents through

83 f EOL care preferences; associations between ACP subtypes and both surrogate-reported EOL care decisi

84 ion models examined for associations between ACP subtypes and measures of treatment intensity.

85 ssays, in silico docking and bioinformatics, ACP residues involved in ACP-PT recognition were identif

86 ty of one enzyme for substrates delivered by ACP and the other by CoA.

87 CP) position paper, initiated and written by ACP's Medical Practice and Quality Committee and approve

88 Formation of the canonical ACP-linked intermediate with fluoromalonyl-CoA allows in

89 eres; while activated cattail pollen carbon (ACP) resembles deflated spheres.

90 g SAM to generate a 3-amino-3-carboxypropyl (ACP) radical.

91 CP to yield an extended beta-ketoacyl chain (ACP = acyl carrier protein).

92 To test this premise, chimeric ACPs were constructed in which L. lactis helix II replac

93 All results showed the presence of a Chinese ACP cluster (CAC) and an American ACP cluster (AAC).

94 In this study, two circular ACP mitogenome sequences from California (mt-CApsy, 15,

95 ia replaced the function of Escherichia coli ACP in lipid biosynthesis.

96 l rechargeable orthodontic cement containing ACP was developed with a high bracket-enamel bond streng

97 ng human adamantinomatous craniopharyngioma (ACP), derived from Sox2- cells in a paracrine manner.

98 t introduced from China based on our current ACP collection but somewhere in America.

99 epothilone module 8, use of dimethylmalonyl-ACP appeared to be the sole route to form a gem-dimethyl

100 s of hydrolysates, each one with distinctive ACP.

101 of HMGS alone and in complex with its donor ACP reveal a tight interaction that depends on exquisite

102 The donor ACP (CurB) had high affinity for the enzyme (Kd = 0.5 mu

103 ing to an unusual surface cleft on the donor ACP, in a manner that would exclude the acceptor ACP.

104 en pre- and postreaction states of the donor ACP.

105 d DPH4ko harbored unmodified eEF2 and DPH5ko ACP- (diphthine-precursor) modified eEF2.

106 by a paralog that produced the enantiomeric ACP-bound diketide caused no changes in processing rates

107 chia coli, AcpP, and its corresponding enoyl-ACP reductase, FabI.

108 InhA, the enoyl-ACP reductase from Mycobacterium tuberculosis, is the ta

109 d the time-dependent inhibition of the enoyl-ACP reductase InhA.

110 recommendation; moderate-quality evidence.) ACP recommends that clinicians and patients select among

111 The possibilities for a sample to exhibit ACP with higher CAA increased with each unit of positive

112 mitogenome sequence analyses will facilitate ACP population research.

113 urD) was examined to establish the basis for ACP selectivity.

114 Editorial consultants from ACP Smart Medicine and MKSAP provide expert review of th

115 Editorial consultants from ACP Smart Medicine and MKSAP provide expert review of th

116 which resulted in the first gain-of-function ACP with improved interactions with its partner enzymes.

117 AS enzymes operate on ACP-bound acyl groups, ACP must stabilize and transport the growing lipid chain

118 ly reversible, as confirmed through the holo ACP-dependent transesterification of the released produc

119 ydratase, distinct from the beta-hydroxyacyl-ACP dehydratase HadABC complex, was constructed in the R

120 [2-(2)H]-(2R,3S)-2-methyl-3-hydroxypentanoyl-ACP (6a) with redox-active, epimerase-inactive EryKR6 fr

121 We used this information to improve ACP compatibility with non-cognate PT domains, which res

122 and bioinformatics, ACP residues involved in ACP-PT recognition were identified.

123 logy, it is unclear whether participation in ACP by patients with cancer has increased over time.

124 Trends in ACP subtypes were tested, and multivariable logistic reg

125 rican College of Physicians (ACP), including ACP Smart Medicine and MKSAP (Medical Knowledge and Self

126 This NFS1-ISD11-ACP (SDA) complex forms the core of the iron-sulfur (Fe-

127 produce epimerized (2S)-2-methyl-3-ketoacyl-ACP (acyl carrier protein) intermediates.

128 is, as predicted, a (2R)-2-methyl-3-ketoacyl-ACP intermediate, came from a newly developed coupled ke

129 on of C2-epimerized (2S)-2-methyl-3-ketoacyl-ACP intermediates.

130 to give the corresponding 2-methy-3-ketoacyl-ACP products during bacterial polyketide biosynthesis me

131 beta-Ketoacyl-ACP synthases (KAS) are key enzymes involved in the type

132 ed exclusively (2R)-2-methyl-3-ketopentanoyl-ACP ((2R)-10).

133 The resulting 2-methyl-3-ketopentanoyl-ACP (10) was incubated separately with five (2R)- or (2S

134 generated [2-(2)H]-2-methyl-3-ketopentanoyl-ACP (4).

135 corresponding (2R)-2-methyl-3-ketopentanoyl-ACP (7a) product.

136 oduct [2-(2)H]-(2R)-2-methyl-3-ketopentanoyl-ACP (7a), consistent with the proposed epimerase activit

137 chemoenzymatically generated 3-ketopentanoyl-ACP (9) were incubated with SAM and BonMT2 from module 2

138 residue predicted to influence ketosynthase-ACP recognition led to improved turnover.

139 Importantly, there was no growth in key ACP domains such as discussions of care preferences.

140 pharmacodynamics of recombinant human LCAT (ACP-501).

141 s residue is followed by transfer to malonyl-ACP to yield an extended beta-ketoacyl chain (ACP = acyl

142 e and enzyme processing of unnatural malonyl-ACP analogues, as well as on the amenability of unnatura

143 activities of two enzymes, MCAT (malonylCoA:ACP transferase) and PDH (pyruvate dehydrogenase).

144 of MbtB to form covalently salicylated MbtB-ACP.

145 -substituted amorphous calcium phosphate (Mg-ACP).

146 lcium phosphate replaces the more soluble Mg-ACP, rendering it both harder and more resistant to acid

147 e highly reducing (hr) PKS class, noncognate ACPs of closely related members complement PKS function.

148 Ion release and re-release from the novel ACP orthodontic cement indicated favorable release and r

149 In the absence of ACP, the complex is destabilized resulting in a profound

150 Recommendations included the adaptation of ACP based on the readiness of the individual; targeting

151 hobic core of ISD11, explaining the basis of ACP stabilization.

152 free phosphopantetheine (Ppant) cofactor of ACP occupies a conserved pocket that excludes the acetyl

153 nsus process to help develop a definition of ACP and provide recommendations for its application.

154 in oncology and beyond, but a definition of ACP and recommendations concerning its use are lacking.

155 Fermentation of ACP mutants of S. lasaliensis in the presence of the pro

156 -phosphopantetheine-conjugated acyl-group of ACP occupies the hydrophobic core of ISD11, explaining t

157 e long-standing recognition of the merits of ACP in oncology, it is unclear whether participation in

158 The transient nature of ACP interactions with these catalytic domains imposes a

159 of the Ppant arm and the transient nature of ACP-enzyme interactions impose a major obstacle to obtai

160 Therefore, the origins of ACP incompatibility can reside in either helix I or in h

161 pectroscopy studies, improved performance of ACP is attributed to its lower charge transfer resistanc

162 ble the pooling and comparison of results of ACP studies.

163 This role of ACP depends upon its covalently bound 4'-phosphopantethe

164 rmations, representing probable snapshots of ACP in action: the 4'-phosphopantetheine group of AcpP f

165 uctures but also provide an animated view of ACP in action during fatty acid dehydration.

166 dynamic action-related structural changes of ACPs using vibrational spectroscopy.

167 tion and ene-cycloisomerization reactions of ACPs.

168 Because FAS enzymes operate on ACP-bound acyl groups, ACP must stabilize and transport

169 resence of P173 with added MMP20, while only ACP particles were seen in the absence of MMP20.

170 r evaluating patients with acute chest pain (ACP).

171 members possess both stearoyl- and palmitoyl-ACP Delta(9) desaturase activity, including the predomin

172 The identification of two Delta9 palmitoyl-ACP desaturases responsible for omega-7 FA biosynthesis,

173 ceeds via Delta(9) desaturation of palmitoyl-ACP followed by elongation of the product.

174 sembled via the alternate chaperone pathway (ACP), are among the most common.

175 stabilizing an amorphous calcium phosphate (ACP) precursor phase.

176 Particles of amorphous calcium phosphate (ACP) were incorporated into PE and PEHB at 40% filler le

177 ription: The American College of Physicians (ACP) and the American Academy of Family Physicians (AAFP

178 The American College of Physicians (ACP) and the Centers for Disease Control and Prevention

179 s paper, the American College of Physicians (ACP) defines a direct patient contracting practice (DPCP

180 The American College of Physicians (ACP) developed this guideline to present the evidence an

181 The American College of Physicians (ACP) developed this guideline to present the evidence an

182 The American College of Physicians (ACP) developed this guideline to present the evidence an

183 ription: The American College of Physicians (ACP) developed this guideline to present the evidence an

184 The American College of Physicians (ACP) developed this guideline to present the evidence an

185 The American College of Physicians (ACP) developed this guideline to present the evidence an

186 The American College of Physicians (ACP) developed this guideline to present the evidence an

187 The American College of Physicians (ACP) developed this guideline to present the evidence an

188 ription: The American College of Physicians (ACP) developed this guideline to present the evidence an

189 ription: The American College of Physicians (ACP) developed this guideline to present the evidence an

190 ription: The American College of Physicians (ACP) developed this guideline to present the evidence an

191 ed care, the American College of Physicians (ACP) is attentive to all voices, including those who spe

192 ly 2014, the American College of Physicians (ACP) issued a guideline presenting the available evidenc

193 This American College of Physicians (ACP) position paper, initiated and written by ACP's Medi

194 tes the 2008 American College of Physicians (ACP) recommendations on treatment of low bone density an

195 n paper, the American College of Physicians (ACP) recommends that physicians and the broader health c

196 ch 2015, the American College of Physicians (ACP) released a clinical guideline on the value of scree

197 urces of the American College of Physicians (ACP), including ACP Smart Medicine and MKSAP (Medical Kn

198 urces of the American College of Physicians (ACP), including MKSAP (Medical Knowledge and Self-Assess

199 urces of the American College of Physicians (ACP), including MKSAP (Medical Knowledge and Self-Assess

200 urces of the American College of Physicians (ACP), including MKSAP (Medical Knowledge and Self-Assess

201 ses from the American College of Physicians (ACP), U.S. Preventive Services Task Force, American Acad

202 NMR spectroscopic analysis of gold pi-ACP complexes and control experiments point to the sp hy

203 e encoding a homologue of the known pimeloyl-ACP methyl ester cleavage enzymes suggesting that it enc

204 equivalence of BioJ to the paradigm pimeloyl-ACP methyl ester carboxyl-esterase, BioH.

205 BioV homologues seem the sole pimeloyl-ACP methyl ester esterase present in the Helicobacter sp

206 leaved the physiological substrate, pimeloyl-ACP methyl ester to pimeloyl-ACP by use of a catalytic t

207 trate, pimeloyl-ACP methyl ester to pimeloyl-ACP by use of a catalytic triad, each member of which wa

208 Advance care planning (ACP) is increasingly implemented in oncology and beyond,

209 Advance care planning (ACP) may prevent end-of-life (EOL) care that is nonbenef

210 reased and was undetectable </=12 hours post ACP-501 infusion.

211 can provide guidance for clinical practice, ACP policy, and research.

212 raction on the antioxidant capacity profile (ACP) of protein hydrolysates from rapeseed (Brassica nap

213 , LA sampling (via ablation crater profiles [ACP]) and aerosol washout/transfer/ICPMS measurement (vi

214 to use dimethylmalonyl acyl carrier protein (ACP) as an extender unit.

215 synthases (NR-PKS) the acyl-carrier protein (ACP) carries the growing polyketide intermediate through

216 chain attached to the acyl carrier protein (ACP) domain of FASN is unknown.

217 and ligation onto the acyl carrier protein (ACP) domain of MbtB to form covalently salicylated MbtB-

218 Mutation of the acyl carrier protein (ACP) domain of the upstream module in one chimera at a r

219 er for the intramodule acyl carrier protein (ACP) domain that carries building blocks and intermediat

220 ion of a 3-hydroxyacyl-acyl carrier protein (ACP) fatty acid synthetic intermediate and also cleaves

221 hylation of 3-ketoacyl-acyl carrier protein (ACP) intermediates to give the corresponding 2-methy-3-k

222 ester bond of pimeloyl-acyl carrier protein (ACP) methyl ester.

223 l NADH-dependent enoyl-acyl-carrier protein (ACP) reductase, InhA.

224 by the bacterial acyl-acyl carrier protein (ACP) synthase AasC but inhibitors of the host acyl-CoA s

225 activity of 3-ketoacyl-acyl carrier protein (ACP) synthase II.

226 the bifunctional acyl-acyl carrier protein (ACP) synthetase/2-acylglycerolphosphoethanolamine acyltr

227 -transferase that uses acyl carrier protein (ACP) to covalently link fatty acids, via an amide bond,

228 subunit B22 anchors an acyl carrier protein (ACP) to the complex, replicating the LYR protein-ACP str

229 Acyl carrier protein (ACP) transports the growing fatty acid chain between enz

230 minimally contains AT, acyl carrier protein (ACP), and ketosynthase (KS) domains.

231 that the mitochondrial acyl carrier protein (ACP), which has a well-known role in FASII, plays an une

232 ne and either cellular acyl carrier protein (ACP)-coupled fatty acids or CoA-aryl/acyl moieties as pr

233 switches largely to an acyl carrier protein (ACP)-independent mode.

234 etected in the tryptic acyl carrier protein (ACP).

235 R protein (ISD11), and acyl carrier protein (ACP).

236 PlsX is an acyl-acyl carrier protein (ACP):phosphate transacylase that interconverts the two a

237 to the complex, replicating the LYR protein-ACP structural module that was identified previously in

238 Acyl carrier proteins (ACPs) are universal and highly conserved domains central

239 ed methods to prepare acyl carrier proteins (ACPs) loaded with substrate mimetics and cross-linkers t

240 ed that expression of acyl carrier proteins (ACPs) of a diverse set of bacteria replaced the function

241 e for two specialized acyl carrier proteins (ACPs) that deliver the donor and acceptor substrates.

242 g of filaments, actin-crosslinking proteins (ACPs) and motors--confers cell structure and functionali

243 is transmitted by the Asian citrus psyllid (ACP) Diaphorina citri, in a circulative manner.

244 Asian citrus psyllid (ACP, Diaphorina citri Kuwayama) transmits "Candidatus Li

245 iastolic (2C) function, acute cor pulmonale (ACP) (1C), pulmonary hypertension (1B), symptomatic pulm

246 At C/10 rate, ACP electrode delivered high specific lithium storage re

247 Recommendation: ACP recommends that clinicians use synovial fluid analys

248 lose of the American College of Physician's (ACP) centennial year is an opportune time to reflect on

249 have a somewhat lower capacity to stabilize ACP and prevent HA formation compared with P173 in the a

250 uish them from the archetype Delta9 stearoyl-ACP desaturase.

251 n the readiness of the individual; targeting ACP content as the individual's health condition worsens

252 Thus, it is likely that ACP is not simply an obligate subunit but also exploits

253 We proposed that ACP in California was likely not introduced from China b

254 Present findings suggest that ACP transformation to ordered arrays of enamel crystals

255 The ACP Clinical Guidelines Committee based these recommenda

256 The ACP domain is differentially and precisely positioned af

257 The ACP provides high-value care screening advice for 5 comm

258 The ACP remains committed to improving care for patients thr

259 The ACP strongly encourages clinicians to adopt a cancer scr

260 The guidelines differ-the ACP guideline recommends against and the ACOG committee

261 that the capping domain opens to enable the ACP domain to dock and to place the acyl chain and 4'-ph

262 extrudes the sequestered acyl chain from the ACP binding pocket before dehydration by repositioning h

263 , and quality; discusses principles from the ACP Ethics Manual, Sixth Edition, that should apply to a

264 of detailed policy recommendations from the ACP to external stakeholders (such as payers, government

265 To further our understanding about how the ACP interacts with the product template (PT) domain that

266 However, the ACP believes that the ethical arguments against legalizi

267 catalytic partner lures the cargo out of the ACP and into the active site of the enzyme, thus enhanci

268 ts initial position after publication of the ACP guideline.

269 tom as controlling the regiochemistry of the ACP hydroamination reaction.

270 riments point to the sp hybridization of the ACP internal alkene carbon atom as controlling the regio

271 troscopic probe on the terminal thiol of the ACP Ppant arm.

272 ontrolled, yet enigmatic coordination of the ACP with its partner enzymes.

273 erns articulated in this position paper, the ACP does not support legalization of physician-assisted

274 merica, and 11 from Australia) who rated the ACP definitions and its 41 recommendations, agreement fo

275 As a result, the ACP recommended against screening for asymptomatic patie

276 ed non-physician facilitators to support the ACP process.

277 Methods: Using the ACP grading system, the committee based these recommenda

278 Using the ACP grading system, the committee based these recommenda

279 Using the ACP grading system, the committee based these recommenda

280 he evidence and recommendations by using the ACP grading system, which is based on the GRADE (Grading

281 he evidence and recommendations by using the ACP grading system, which is based on the GRADE (Grading

282 hesized a SAM analogue (SAMCA), in which the ACP group of SAM is replaced with a 3-carboxyallyl group

283 They review the data on which the ACP/CDC recommendations are based and discuss the potent

284 elop In the Clinic in collaboration with the ACP's Medical Education and Publishing divisions and wit

285 se primary sources in collaboration with the ACP's Medical Education and Publishing divisions and wit

286 elop In the Clinic in collaboration with the ACP's Medical Education and Publishing divisions and wit

287 se primary sources in collaboration with the ACP's Medical Education and Publishing divisions and wit

288 elop In the Clinic in collaboration with the ACP's Medical Education and Publishing divisions and wit

289 This ACP position paper, initiated and written by its Medical

290 olvatochromic pantetheine probes attached to ACP that fluoresce when sequestered.

291 so cleaves the thioester bond linking DSF to ACP.

292 ure becomes increasingly complex from PCP to ACP.

293 istic features--specifically actin turnover, ACP (un)binding and motor walking--to reveal the nature

294 he local environment of the Ppant arm of two ACPs previously characterized by solution NMR, and was u

295 Understanding ACP population diversity is necessary for HLB regulatory

296 nce and strength of recommendations by using ACP's clinical practice guidelines grading system.

297 es the evidence and recommendations by using ACP's guideline grading system.

298 rades the evidence and recommendations using ACP's clinical practice guidelines grading system.

299 It is unknown whether ACP results in less cerebral injury than DHCA.

300 However, more studies with ACP samples from around the world are needed.